Discovery of a class of calcium sensing receptor positive allosteric modulators; 1-(benzothiazol-2-yl)-1-phenylethanols

https://doi.org/10.1016/j.bmcl.2010.07.077Get rights and content

Abstract

1-(Benzothiazol-2-yl)-1-(4-chlorophenyl)ethanol (1) was identified as a positive allosteric modulator (PAM) of the CaSR in a functional cell-based assay. This compound belongs to a class of compounds that is structurally distinct from other known positive allosteric modulators, for example, the phenylalkylamines cinacalcet, a modified analog (13) potently suppressed parathyroid hormone (PTH) release in rats, consistent with its profile as a PAM of CaSRs.

Graphical abstract

1-(Benzothiazol-2-yl)-1-(4-chlorophenyl)ethanol (1) was identified as a positive allosteric modulator (PAM) of the CaSR in a functional cell-based assay. This compound belongs to a class of compounds that is structurally distinct from other known positive allosteric modulators e.g., the phenylalkylamines cinacalcet, a modified analog (13) potently suppressed parathyroid hormone (PTH) release in rats, consistent with its profile as a PAM of CaSRs.

  1. Download : Download full-size image

Section snippets

Acknowledgment

We thank Associate Professor Lars Eriksson for determining the X-ray structure of compound (S)-13.

References and notes (16)

  • J.A. Lewis et al.

    Curr. Opin. Chem. Biol.

    (2008)
  • H. Gilman et al.

    J. Am. Chem. Soc.

    (1949)
  • R.L. Thomas et al.

    J. Pharmacol. Exp. Ther.

    (2008)
  • R. Trivedi et al.

    Curr. Med. Chem.

    (2008)
  • A.A. Jensen et al.

    Curr. Neuropharmacol.

    (2007)
  • E.M. Brown et al.

    Physiol. Rev.

    (2001)
  • A.M. Hofer et al.

    Nat. Rev. Mol. Cell Biol.

    (2003)
  • B. Bettler et al.

    Physiol. Rev.

    (2004)
There are more references available in the full text version of this article.

Cited by (9)

  • Discovery and Development of Calcimimetic and Calcilytic Compounds

    2018, Progress in Medicinal Chemistry
    Citation Excerpt :

    Researchers at ACADIA Pharmaceuticals screened 250,000 small drug-like compounds using a functional cellular assay termed Receptor Selection and Amplification Technology that couples the CaR to a readout of cellular proliferation. This assay identified a number of hits representing distinct chemotypes, but the actual number is not specified [112]. Of the distinct structures identified, the benzothiazole chemotype, represented by compound 76, was selected because it differs significantly from the phenyl- and naphthylalkylamines and lacks a positive charge.

View all citing articles on Scopus
View full text